Steno Diabetes Center Copenhagen

🇩🇰Denmark

Country: 🇩🇰Denmark

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Spironolactone in Diabetic Nephropathy

Phase 4

Completed

Conditions: Diabetic Nephropathy

First Posted Date: 2006-04-25

Last Posted Date: 2006-04-25

Lead Sponsor: Steno Diabetes Center Copenhagen

Target Recruit Count: 48

Registration Number: NCT00317954

Locations: 🇩🇰
Steno Diabetes Center, Gentofte, Denmark

Renoprotective Effect of Nisoldipine and Lisinopril in Type 1 Diabetic Nephropathy

Phase 4

Completed

Conditions: Diabetic Nephropathy

First Posted Date: 2006-04-06

Last Posted Date: 2006-04-06

Lead Sponsor: Steno Diabetes Center Copenhagen

Target Recruit Count: 52

Registration Number: NCT00311870

Locations: 🇩🇰
Steno Diabetes Center, Gentofte, Denmark

Effect of Metformin Versus Repaglinide Treatment in Non-Obese Type 2 Diabetic Patients Uncontrolled by Diet

Phase 4

Completed

Conditions: Diabetes Mellitus, Type 2

Interventions: Other: Diet-only.
Drug: Metformin
Drug: Repaglinide
Drug: Placebo-Metformin.
Drug: Placebo-Repaglinide.

First Posted Date: 2005-07-12

Last Posted Date: 2008-12-08

Lead Sponsor: Steno Diabetes Center Copenhagen

Target Recruit Count: 100

Registration Number: NCT00118950

Locations: 🇩🇰
Steno Diabetes Center, Gentofte, Denmark

Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney Disease

Not Applicable

Completed

Conditions: Diabetes Mellitus, Type I
Diabetic Nephropathy

First Posted Date: 2005-07-12

Last Posted Date: 2006-11-23

Lead Sponsor: Steno Diabetes Center Copenhagen

Target Recruit Count: 60

Registration Number: NCT00118976

Locations: 🇩🇰
Steno Diabetes Center, Gentofte, Denmark

Effect of Repaglinide Versus Metformin Treatment in Non-Obese Patients With Type-2-Diabetes

Phase 4

Completed

Conditions: Diabetes Mellitus, Type 2

Interventions: Drug: Metformin
Drug: Insulin BIAsp30 (Novolog 70/30)
Drug: Repaglinide
Drug: Placebo-Repaglinide
Drug: Placebo-Metformin

First Posted Date: 2005-07-12

Last Posted Date: 2008-12-08

Lead Sponsor: Steno Diabetes Center Copenhagen

Target Recruit Count: 102

Registration Number: NCT00118963

Locations: 🇩🇰
Steno Diabetes Center, Gentofte, Denmark

Effect of Metformin in Patients With Type-1 Diabetes With Inadequate Glycaemic Control by Insulin and Diet

Phase 4

Completed

Conditions: Diabetes Mellitus, Type 1

Interventions: Drug: Placebo.
Drug: Metformin

First Posted Date: 2005-07-12

Last Posted Date: 2008-12-08

Lead Sponsor: Steno Diabetes Center Copenhagen

Target Recruit Count: 100

Registration Number: NCT00118937

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy